Ozempic Could Prevent Diabetes. Should We Use It For That?

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a use for the drugs.

What Democrats Should Learn From Their Loss

Readers point to campaign missteps and offer advice for winning back voters. Also: Robert F. Kennedy Jr.’s role in health policy; closing local pharmacies.

Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning.

What to Know About Plan B: Cost, Effectiveness and Legality

We asked experts how it works, when you should take it, how much it costs and more.

Richard Pazdur, FDA Cancer Chief, Discusses 25 Years of Innovation

Dr. Richard Pazdur for 25 years has overseen innovations in the treatment of deadly diseases at the agency.

F.D.A. Wants to Pull Ineffective Decongestant From Stores

It was added to cold and flu remedies in the 1990s when another ingredient went behind the counter over illicit meth lab concerns.

El medicamento innovador para vencer la adicción: ¿Ozempic?

Los primeros datos sugieren que los fármacos GLP-1, conocidos por su capacidad para ayudar a perder peso, podrían tener un poderoso efecto en el tratamiento de la adicción.

Robert F. Kennedy Jr. se prepara para ejercer el poder en salud pública

El presidente electo, Donald Trump, lo ha animado a “descocarse en materia de salud”, pero no ha aclarado qué papel jugará Kennedy.

Robert F. Kennedy Jr., Foe of Drug Makers and Regulators, Is Poised to Wield New Power

President-elect Donald Trump has encouraged him to “go wild on health” but has not made clear what role Mr. Kennedy will play.

El medicamento innovador para vencer la adicción: ¿Ozempic?

Los primeros datos sugieren que los fármacos GLP-1, conocidos por su capacidad para ayudar a perder peso, podrían tener un poderoso efecto en el tratamiento de la adicción.